Upfront Use of 177Lu-Labeled PSMA Radioligand Therapy and Treatment Response Assessment in Treatment-Naive Prostate Cancer

Upfront Use of 177Lu-Labeled PSMA Radioligand Therapy and Treatment Response Assessment in Treatment-Naive Prostate Cancer

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine
Main Authors: Malik, Dharmender, Sen, Ishita B., Thakral, Parul, Das, Subha Shankar, Manda, Divya, CB, Virupakshappa
Format: Journal Article
Language:English
Published: Wolters Kluwer Health, Inc. All rights reserved 13-09-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0363-9762
DOI:10.1097/RLU.0000000000003890